Literature DB >> 35547353

Prognostic Factors of Clinical and Economic Outcomes of Hip Arthroplasty in a Developing Country: A Multilevel Analysis with a 4-Year Cohort Study.

Laura López-Rincón1,2, Tomás Martínez1, Juan Herrera-Rodríguez1,2, Álvaro Daniel Trejos1,2, Giancarlo Buitrago2,3.   

Abstract

Introduction: This study is aimed at estimating the 30-day postoperative mortality rate and total costs of the medical episode, as well as determining prognostic factors associated with these outcomes for adult patients who have undergone total hip arthroplasty (THA) in Colombia's contributory health system.
Methods: This was a retrospective cohort using administrative data and included adult patients enrolled in Colombia's contributory health system who underwent THA between the years 2011 and 2014. Outcomes were 30-day mortality ICU admissions, and the 1-year rate of fractures and revisions as well as the total cost of the medical episode incurred by the third-payer for 90 days following the procedure. Multilevel linear regression models were also generated to determine the prognostic factors associated with the outcomes presented.
Results: The study included 17,289 patients, with an average age of 67 years. Outcome rates were calculated per 100 surgeries, resulting in 2.15 for mortality, 3.41 for ICU admissions, 2.42 for revision hip arthroplasty and 0.62 for periprosthetic fractures. This study found the age and Charlson Comorbidity Index were associated with mortality and complications, and that being female and performing the procedure in the capital city were protective factors. It also found that the median total cost of the medical episode was USD $ USD$2742.161 (p25-p75: 353.092-3291.747). The multivariate model found increasing trends in cost as age and CCI scores rose, and higher costs in the Atlantic region. Conclusions: Colombia has higher rates of complications from THA than other countries but lower health system costs. For these patients, age, CCI and the geographic region are factors that are associated with mortality, complications, and health system costs. © Indian Orthopaedics Association 2021.

Entities:  

Keywords:  Arthroplasty; Hip; Mortality; Outcomes; Reoperation; Replacement

Year:  2022        PMID: 35547353      PMCID: PMC9043143          DOI: 10.1007/s43465-021-00590-4

Source DB:  PubMed          Journal:  Indian J Orthop        ISSN: 0019-5413            Impact factor:   1.033


  20 in total

1.  Arthroscopic versus open shoulder stabilization for recurrent anterior instability: a prospective randomized clinical trial.

Authors:  Craig R Bottoni; Eric L Smith; Mark J Berkowitz; Robert B Towle; Josef H Moore
Journal:  Am J Sports Med       Date:  2006-05-30       Impact factor: 6.202

2.  Unplanned admission to the intensive care unit after total hip arthroplasty.

Authors:  Atul F Kamath; Caitlin L McAuliffe; Keith D Baldwin; Jared B Lucas; Laura M Kosseim; Craig L Israelite
Journal:  J Arthroplasty       Date:  2012-03-06       Impact factor: 4.757

3.  Impact of Gender on 30-Day Complications After Primary Total Joint Arthroplasty.

Authors:  Jonathan Robinson; John I Shin; James E Dowdell; Calin S Moucha; Darwin D Chen
Journal:  J Arthroplasty       Date:  2017-03-10       Impact factor: 4.757

4.  Clinical Outcomes, Health Care Costs and Prognostic Factors for Total Knee Arthroplasty: A Multilevel Analysis of a National Cohort Study Using Administrative Claims Data.

Authors:  Giancarlo Buitrago; Jorge R Ortiz; Felipe Camacho
Journal:  J Knee Surg       Date:  2020-08-24       Impact factor: 2.757

5.  Thirty-day mortality after elective hip and knee arthroplasty.

Authors:  E J Smith; M Maru; A Siegmeth
Journal:  Surgeon       Date:  2014-01-24       Impact factor: 2.392

Review 6.  Manual Therapy for Hip Osteoarthritis: A Systematic Review and Meta-analysis.

Authors:  Qiong Wang; Teng-teng Wang; Xiao-feng Qi; Min Yao; Xue-jun Cui; Yong-jun Wang; Qian-qian Liang
Journal:  Pain Physician       Date:  2015-11       Impact factor: 4.965

Review 7.  Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.

Authors:  John G Meara; Andrew J M Leather; Lars Hagander; Blake C Alkire; Nivaldo Alonso; Emmanuel A Ameh; Stephen W Bickler; Lesong Conteh; Anna J Dare; Justine Davies; Eunice Dérivois Mérisier; Shenaaz El-Halabi; Paul E Farmer; Atul Gawande; Rowan Gillies; Sarah L M Greenberg; Caris E Grimes; Russell L Gruen; Edna Adan Ismail; Thaim Buya Kamara; Chris Lavy; Ganbold Lundeg; Nyengo C Mkandawire; Nakul P Raykar; Johanna N Riesel; Edgar Rodas; John Rose; Nobhojit Roy; Mark G Shrime; Richard Sullivan; Stéphane Verguet; David Watters; Thomas G Weiser; Iain H Wilson; Gavin Yamey; Winnie Yip
Journal:  Lancet       Date:  2015-04-26       Impact factor: 79.321

Review 8.  Population-based rates of revision of primary total hip arthroplasty: a systematic review.

Authors:  Kelly L Corbett; Elena Losina; Akosua A Nti; Julian J Z Prokopetz; Jeffrey N Katz
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

9.  Infection burden in total hip and knee arthroplasties: an international registry-based perspective.

Authors:  Bryan D Springer; September Cahue; Caryn D Etkin; David G Lewallen; Brian J McGrory
Journal:  Arthroplast Today       Date:  2017-06-20

Review 10.  Hip Osteoarthritis: Etiopathogenesis and Implications for Management.

Authors:  Nicholas J Murphy; Jillian P Eyles; David J Hunter
Journal:  Adv Ther       Date:  2016-09-26       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.